J&J to buy Halda Therapeutics in US$3.05 billion cash deal
Johnson & Johnson has agreed to buy the cancer treatment biotech Halda Therapeutics for US$3.05 billion cash, part of a ...
Tag: Therapeutics
Lightstone Ventures, Temasek’s ClavystBio co-lead Allay Therapeutics’ US$57.5 million Series D funding
The company’s technology is used to create analgesic products that can aid patients with post-surgical pain management and recuperation United ...
Roche to acquire cell therapy maker Poseida Therapeutics in US$1.5 billion deal
SWITZERLAND’S Roche will acquire its US collaboration partner Poseida Therapeutics in a cash deal worth up to US$1.5 billion, banking ...
A28 Therapeutics Announces Late-Stage Clinical Development Of Cancer-Killing AT-101 Lytic Peptide Molecule
A28 Therapeutics, a privately-held, clinical-stage biopharmaceutical company focused on the development of cancer treatments, has announced that its AT-101 lytic ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
NEWS
- Business
- Technology
- Entertainment
- Sports
- Lifestyle
- Health
- Politics
- Real Estate
© 2026 The New York Journals. All Rights Reserved.